Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 1/2009

01.08.2009

Redox-Reactive Autoantibodies: Biochemistry, Characterization, and Specificities

verfasst von: John A. McIntyre, W. Page Faulk

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Oxidation–reduction (redox) reactions can “unmask” autoantibody activity in blood and other body fluids from normal, healthy individuals. These “unmasked” autoantibodies are similar if not identical to autoantibodies associated with autoimmune diseases. The agents responsible for this unmasking are physiological oxidants such as hemin and likely other naturally occurring molecules in the body that contain transitional metals available for participation in redox reactions. Laboratory comparisons between oxidized and non oxidized IgG fail to show differences to account for the oxidation-induced alteration of antibody specifics. The autoantibodies unmasked by redox reactivities represent a growing list of specificities, many that are responsible for modulating and/or regulating intracellular functions. In contrast, alloantibodies, such as anti-HLA antibodies, do not exhibit susceptibility to oxidation-induced autoantibody alterations, suggesting differences in the amino acids responsible for forming the complementarity determining regions of these respective antibody molecules. We have proposed that such reversible oxidative conversions of antibody reactivities represent a heretofore undiscovered, but an evolutionary-conserved, resource of innate humoral immunity destined to maintain an immunological homeostasis.
Literatur
1.
Zurück zum Zitat Shoenfeld Y, Gershwin ME, Meroni PL (eds) (2008) Autoantibodies, 2nd edn. Elsevier, Philadelphia Shoenfeld Y, Gershwin ME, Meroni PL (eds) (2008) Autoantibodies, 2nd edn. Elsevier, Philadelphia
2.
Zurück zum Zitat Silverstein AM (2001) Autoimmunity versus horror autotoxicus: the struggle for recognition. Nat Immunol 2:279–281PubMedCrossRef Silverstein AM (2001) Autoimmunity versus horror autotoxicus: the struggle for recognition. Nat Immunol 2:279–281PubMedCrossRef
3.
Zurück zum Zitat National Institutes of Health, The Autoimmune Diseases Coordinating Committee (2005) Progress in autoimmune diseases research. Report to Congress. U.S. Department of Health and Human Services, March National Institutes of Health, The Autoimmune Diseases Coordinating Committee (2005) Progress in autoimmune diseases research. Report to Congress. U.S. Department of Health and Human Services, March
4.
Zurück zum Zitat Gershwin LJ (2007) Veterinary autoimmunity: autoimmune diseases in domestic animals. Ann N Y Acad Sci 1109:109–116PubMedCrossRef Gershwin LJ (2007) Veterinary autoimmunity: autoimmune diseases in domestic animals. Ann N Y Acad Sci 1109:109–116PubMedCrossRef
5.
Zurück zum Zitat McIntyre JA (2004) The appearance and disappearance of antiphospholipid antibodies subsequent to oxidation–reduction reactions. Thromb Res 114:579–587PubMedCrossRef McIntyre JA (2004) The appearance and disappearance of antiphospholipid antibodies subsequent to oxidation–reduction reactions. Thromb Res 114:579–587PubMedCrossRef
6.
Zurück zum Zitat McIntyre JA, Wagenknecht DR, Faulk WP (2005) Autoantibodies unmasked by redox reactions. J Autoimmun 24:311–317PubMedCrossRef McIntyre JA, Wagenknecht DR, Faulk WP (2005) Autoantibodies unmasked by redox reactions. J Autoimmun 24:311–317PubMedCrossRef
7.
Zurück zum Zitat McIntyre JA, Wagenknecht DR, Faulk WP (2003) Antiphospholipid antibodies: discovery, definition, detection and disease. Prog Lipid Res 42:176–237PubMedCrossRef McIntyre JA, Wagenknecht DR, Faulk WP (2003) Antiphospholipid antibodies: discovery, definition, detection and disease. Prog Lipid Res 42:176–237PubMedCrossRef
8.
Zurück zum Zitat McIntyre JA, Wagenknecht DR, Faulk WP (2006) Redox-reactive autoantibodies: detection and physiological relevance. Autoimmun Rev 5:76–83PubMedCrossRef McIntyre JA, Wagenknecht DR, Faulk WP (2006) Redox-reactive autoantibodies: detection and physiological relevance. Autoimmun Rev 5:76–83PubMedCrossRef
9.
Zurück zum Zitat Fellouse FA, Barthelemy PA, Kelley RF, Sidhu SS (2006) Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code. J Mol Biol 357:100–114PubMedCrossRef Fellouse FA, Barthelemy PA, Kelley RF, Sidhu SS (2006) Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code. J Mol Biol 357:100–114PubMedCrossRef
10.
Zurück zum Zitat Cabiedes J, Cabral AR, Alarcón-Segovia (1998) Hidden anti-phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments. Eur J Immunol 7:2108–2114CrossRef Cabiedes J, Cabral AR, Alarcón-Segovia (1998) Hidden anti-phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments. Eur J Immunol 7:2108–2114CrossRef
11.
Zurück zum Zitat Lorber M, Shoenfeld Y (2000) Hidden autoantibodies. Clin Rev Allergy Immunol 1:51–58CrossRef Lorber M, Shoenfeld Y (2000) Hidden autoantibodies. Clin Rev Allergy Immunol 1:51–58CrossRef
12.
Zurück zum Zitat Tomer Y, Shoenfeld Y (1988) The significance of natural autoantibodies. Immunol Invest 5:389–424CrossRef Tomer Y, Shoenfeld Y (1988) The significance of natural autoantibodies. Immunol Invest 5:389–424CrossRef
13.
Zurück zum Zitat Matsuura E, Hughes GRV, Khamashta MA (2008) Oxidation of LDL and its clinical implication. Autoimmun Rev 7:558–566PubMedCrossRef Matsuura E, Hughes GRV, Khamashta MA (2008) Oxidation of LDL and its clinical implication. Autoimmun Rev 7:558–566PubMedCrossRef
14.
Zurück zum Zitat Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924PubMed Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924PubMed
15.
Zurück zum Zitat Tabuchi M, Inoue K, Usui-Kataoka H, Kobayashi K, Teramoto M, Takasugi K et al (2007) The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis. J Lipid Res 48:768–781PubMedCrossRef Tabuchi M, Inoue K, Usui-Kataoka H, Kobayashi K, Teramoto M, Takasugi K et al (2007) The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis. J Lipid Res 48:768–781PubMedCrossRef
16.
Zurück zum Zitat Shoenfeld Y, Wu R, Dearing LD, Matsuura E (2004) Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? Circulation 110:2552–2558PubMedCrossRef Shoenfeld Y, Wu R, Dearing LD, Matsuura E (2004) Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? Circulation 110:2552–2558PubMedCrossRef
17.
Zurück zum Zitat Matsuura E, Kobayashi K, Tabuchi M, Lopez LR (2006) Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 45:466–486PubMedCrossRef Matsuura E, Kobayashi K, Tabuchi M, Lopez LR (2006) Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 45:466–486PubMedCrossRef
18.
Zurück zum Zitat Camejo G, Halberg C, Monschik-Lundin A et al (1998) Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res 39:755–766PubMed Camejo G, Halberg C, Monschik-Lundin A et al (1998) Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res 39:755–766PubMed
19.
Zurück zum Zitat Miller YI, Shaklai N (1999) Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Biochim Biophys Acta 1454:153–164PubMed Miller YI, Shaklai N (1999) Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Biochim Biophys Acta 1454:153–164PubMed
20.
Zurück zum Zitat McIntyre JA, Faulk WP (eds) (2008) Special issue: redox and autoimmunity. Autoimmun Rev 7:515–584 McIntyre JA, Faulk WP (eds) (2008) Special issue: redox and autoimmunity. Autoimmun Rev 7:515–584
Metadaten
Titel
Redox-Reactive Autoantibodies: Biochemistry, Characterization, and Specificities
verfasst von
John A. McIntyre
W. Page Faulk
Publikationsdatum
01.08.2009
Verlag
Humana Press Inc
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 1/2009
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-008-8093-y

Weitere Artikel der Ausgabe 1/2009

Clinical Reviews in Allergy & Immunology 1/2009 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.